ENDOGEN ApS: Financial statements 2015
CVR: 29813337
Source: annual report 2015, Danish Business Authority
27/10/2014 – 26/10/2015
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 18,574 and a net result of DKK -16,471 compared with DKK -36,822 the year before. That is a decrease of 0.3% compared with the year before. The profit margin was -88.7%. Equity in the 2015 report amounted to DKK 56,122. The solvency ratio was 100%.
- Revenue
- DKK 18,574
- Gross Profit
- DKK -16,157
- Profit/Loss
- DKK -16,471
- Equity
- DKK 56,122
- Total Assets
- DKK 56,122
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
How creditworthy is ENDOGEN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
ENDOGEN ApS has published its annual report for 2014. Revenue came to DKK 18,625, and the net result was DKK -36,822.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.